Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report. [electronic resource]
Producer: 20130429Description: 413-20 p. digitalISSN:- 1432-2072
- Behavior, Addictive -- physiopathology
- Blood Pressure -- drug effects
- Cholinesterase Inhibitors -- therapeutic use
- Cognition -- drug effects
- Connecticut
- Cross-Over Studies
- Double-Blind Method
- Female
- Galantamine -- therapeutic use
- Heart Rate -- drug effects
- Humans
- Infusions, Intravenous
- Logistic Models
- Male
- Neuropsychological Tests
- Nicotine -- administration & dosage
- Nicotinic Agonists -- administration & dosage
- Pilot Projects
- Severity of Illness Index
- Smoking -- physiopathology
- Smoking Cessation -- methods
- Smoking Prevention
- Substance Withdrawal Syndrome -- physiopathology
- Surveys and Questionnaires
- Task Performance and Analysis
- Time Factors
- Tobacco Use Disorder -- drug therapy
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.